Procedural Advantages of a Novel Drug-Eluting Coronary Stent
NCT02881216
·
clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
814
Enrollment
OTHER
Sponsor class
Conditions
Coronary Artery Disease
Interventions
DEVICE:
Synergy Stent
DEVICE:
Currently common drug-eluting stent (DES)
Sponsor
University Hospital Heidelberg